Improving management and outcomes of the Boston type 1 keratoprosthesis: lessons learned from available evidence

References

• Dohlman CH, Doane MG. Some factors influencing outcome after keratoprosthesis surgery. Cornea 1994;13:214-18
   PubMed Web of Science ®Google Scholar
• Stone WJr, Herbert E. Experimental study of plastic material as replacement for the cornea; a preliminary report. Am J Ophthalmol 1953;36:168-73
   PubMed Web of Science ®Google Scholar
• Harissi-Dagher M, Khan BF, Schaumberg DA, et al. Importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis. Cornea 2007;26:564-8
   PubMed Web of Science ®Google Scholar
• Dohlman CH, Harissi-Dagher M. The Boston Keratoprosthesis: a new threadless design. Digital J Ophthalmol 2007.13 Available from: www.djo.harvard.edu/site.php?url=/physicians/oa/1055 [Last accessed 7 February 2015]
   Google Scholar
• Todani A, Ciolino JB, Ament JD, et al. Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Arch Clin Exp Ophthalmol 2011;249:1515-18
   PubMed Web of Science ®Google Scholar
• Ament JD, Spurr-Michaud SJ, Dohlman CH, et al. The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea 2009;28:808-11
   PubMed Web of Science ®Google Scholar
• Cruzat A, Shukla A, Dohlman CH, et al. Wound anatomy after type 1 Boston KPro using oversized back plates. Cornea 2013;32:1531-6
   PubMed Web of Science ®Google Scholar
• Sayegh RR, Avena Diaz L, Vargas-Martin F, et al. Optical functional properties of the Boston Keratoprosthesis. Invest Ophthalmol Vis Sci 2010;51:857-63
   PubMed Web of Science ®Google Scholar
• Harissi-Dagher M, Beyer J, Dohlman CH. The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin 2008;48:43-51
   PubMedGoogle Scholar
• Shapiro BL, Cortes DE, Chin EK, et al. High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis. Cornea 2013;32:951-5
   PubMed Web of Science ®Google Scholar
• Kang JJ, Allemann N, Vajaranant TS, et al. Anterior segment optical coherence tomography for the quantitative evaluation of the anterior segment following Boston keratoprosthesis. PLoS ONE 2013;8:e70673
   PubMed Web of Science ®Google Scholar
• Kang JJ, Allemann N, Cruz JD, et al. Serial analysis of anterior chamber depth and angle status using anterior segment optical coherence tomography after Boston Keratoprosthesis. Cornea 2013;32:1369-74
   PubMed Web of Science ®Google Scholar
• Qian CX, Hassanaly S, Harissi-Dagher M. Anterior segment optical coherence tomography in the long-term follow-up and detection of glaucoma in Boston Type I Keratoprosthesis. Ophthalmology 2015;122:317-25
   PubMed Web of Science ®Google Scholar
• Paschalis EI, Chodosh J, Spurr-Michaud S, et al. In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci 2013;54:3863-73
   PubMed Web of Science ®Google Scholar
• Dohlman CH, Abad JC, Dudenhoefer EJ, et al. Keratoprosthesis: beyond corneal graft failure. In: Spaeth G, editor. Ophthalmic surgery Principles and practice. Philadelphia: WB Saunders;2003.p. 199-2007
   Google Scholar
• Robert MC, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea 2012;31:339-45
   PubMed Web of Science ®Google Scholar
• Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea 2001;20:19-23
   PubMed Web of Science ®Google Scholar
• Ma JJ, Graney JM, Dohlman CH. Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin 2005;45:49-59
   PubMedGoogle Scholar
• Akpek EK, Harissi-Dagher M, Petrarca R, et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol 2007;144:227-31
   PubMed Web of Science ®Google Scholar
• Hassanaly SI, Talajic JC, Harissi-Dagher M. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal. Am J Ophthalmol 2014;158:270-6
   PubMed Web of Science ®Google Scholar
• Robert MC, Harissi-Dagher M. Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol 2011;46:164-8
   PubMed Web of Science ®Google Scholar
• Khan BF, Harissi-Dagher M, Pavan-Langston D, et al. The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol 2007;125:745-9
   PubMedGoogle Scholar
• Pavan-Langston D, Dohlman CH. Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology 2008;115:S21-3
   Google Scholar
• Harissi-Dagher M, Dohlman CH. The Boston Keratoprosthesis in severe ocular trauma. Can J Ophthalmol 2008;43:165-9
   PubMed Web of Science ®Google Scholar
• Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye 2009;23:1966-71
   PubMed Web of Science ®Google Scholar
• Aquavella JV, Gearinger MD, Akpek EK, et al. Pediatric keratoprosthesis. Ophthalmology 2007;114:989-94
   PubMed Web of Science ®Google Scholar
• Cade F, Grosskreutz CL, Tauber A, et al. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis. Cornea 2011;30:1322-7
   PubMedGoogle Scholar
• Ciolino JB, Belin MW, Todani A, et al. Boston Keratoprosthesis Type 1 Study Group. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2013;120:1195-200
   PubMed Web of Science ®Google Scholar
• Srikumaran D, Munoz B, Aldave AJ, et al. Long-term outcomes of Boston Type 1 Keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology 2014;121:2159-64
   PubMed Web of Science ®Google Scholar
• Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea 2009;28:896-901
   PubMed Web of Science ®Google Scholar
• Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001;119:484-9
   PubMedGoogle Scholar
• Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol 2012;96:776-80
   PubMed Web of Science ®Google Scholar
• Aaberg TMJr, Flynn HWJr, Schiffman J, et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 1998;105:1004-10
   PubMed Web of Science ®Google Scholar
• Ramchandran RS, Diloreto DAJr, Chung MM, et al. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis. Ophthalmology 2012;119:674-81
   PubMed Web of Science ®Google Scholar
• Alvarez de Toledo J, Barraquer RI, Temprano J. Osteo-odonto-keratoprosthesis: a 30-year retrospective study. An Inst Barraquer 1999;28(Suppl):95-100
   Google Scholar
• Najem K, Sebag M, Harissi-Dagher M. Boston keratoprosthesis type 1 device leak. Can J Ophthalmol 2014;49:106-8
   PubMed Web of Science ®Google Scholar
• Chan CC, Holland EJ. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea 2012;31:346-9
   PubMed Web of Science ®Google Scholar
• Fintelmann RE, Maguire JI, Ho AC, et al. Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea 2009;28:877-8
   PubMed Web of Science ®Google Scholar
• Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea 2007;26:9-15
   PubMed Web of Science ®Google Scholar
• Robert MC, Eid EP, Saint-Antoine P, et al. Microbial colonization and antibacterial resistance patterns after Boston type 1 keratoprosthesis. Ophthalmology 2013;120:1521-8
   PubMed Web of Science ®Google Scholar
• Magalhaes FP, do Nascimento HM, Ecker DJ, et al. Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine. Cornea 2013;32:407-11
   PubMed Web of Science ®Google Scholar
• Kim MJ, Yu F, Aldave AJ. Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes. Ophthalmology 2013;120:2209-16
   PubMed Web of Science ®Google Scholar
• Aldave AJ, Kamal KM, Vo RC, et al. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 2009;116:640-51
   PubMed Web of Science ®Google Scholar
• Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea 2009;28:989-96
   PubMed Web of Science ®Google Scholar
• Robert MC, Dohlman CH. A review of corneal melting after Boston keratoprosthesis. Semin Ophthalmol 2014;29:349-57
   PubMed Web of Science ®Google Scholar
• Sivaraman KR, Hou JH, Allemann N. Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston Keratoprosthesis. Am J Ophthalmol 2013;155:814-22
   PubMed Web of Science ®Google Scholar
• Utine CA, Tzu JH, Akpek EK. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt. Ocul Immunol Inflamm 2011;19:413-18
   PubMed Web of Science ®Google Scholar
• Arafat SN, Suelves AM, Spurr-Michaud S, et al. Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with Stevens-Johnson syndrome and ocular cicatricial pemphigoid. Ophthalmology 2014;121:79-87
   PubMed Web of Science ®Google Scholar
• Brejchova K, Liskova P, Cejkova J, et al. Role of matrix metalloproteinases in recurrent corneal melting. Exp Eye Res 2010;90:583-90
   PubMedGoogle Scholar
• Kanellopoulos AJ, Asimellis G. Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in Boston keratoprosthesis type 1. Cornea 2014;33:914-18
   PubMed Web of Science ®Google Scholar
• Robert MC, Arafat SN, Ciolino JB. Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients. Eye Contact Lens 2014;40:376-81
   PubMedGoogle Scholar
• Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology 2011;118:1543-50
   PubMed Web of Science ®Google Scholar
• Wang Q, Harissi-Dagher M. Characteristics and management of patients with Boston Type 1 keratoprosthesis explantation-the University of Montreal Hospital Center Experience. Am J Ophthalmol 2014;158(6):1297-304. e1
   Google Scholar
• Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea 2009;28:321-7
   PubMed Web of Science ®Google Scholar
• Rudnisky CJ, Belin MW, Todani A, et al. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2012;119:951-5
   PubMed Web of Science ®Google Scholar
• Stacy RC, Jakobiec FA, Michaud NA, et al. Characterization of retrokeratoprosthetic membranes in the Boston type 1 keratoprosthesis. Arch Ophthalmol 2011;129:310-16
   PubMedGoogle Scholar
• Patel AP, Wu EI, Ritterband DC, et al. Boston type 1 keratoprosthesis: the New York Eye and Ear experience. Eye 2012;26:418-25
   PubMed Web of Science ®Google Scholar
• Sejpal K, Yu F, Aldave AJ. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea 2011;30:1187-94
   PubMed Web of Science ®Google Scholar
• Klufas MA, Yannuzzi NA, D’Amico DJ, et al. Vitreoretinal aspects of permanent keratoprosthesis. Surv Ophthalmol 2014; published online 11 November 2014; 10.1016/j.survophthal.2014.11.001
   PubMedGoogle Scholar
• Chak G, Aquavella JV. A safe Nd:YAG retroprosthetic membrane removal technique for keratoprosthesis. Cornea 2010;29:1169-72
   PubMed Web of Science ®Google Scholar
• Ray S, Khan BF, Dohlman CH, et al. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol 2002;120:559-66
   PubMedGoogle Scholar
• Kiang L, Sippel KC, Starr CE, et al. Vitreoretinal surgery in the setting of permanent keratoprosthesis. Arch Ophthalmol 2012;130:487-92
   PubMedGoogle Scholar
• Goldman DR, Hubschman JP, Aldave AJ, et al. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina 2013;33:532-41
   PubMed Web of Science ®Google Scholar
• Grassi CM, Crnej A, Paschalis EI, et al. Idiopathic vitritis in the setting of Boston keratoprosthesis. Cornea 2015;34:165-70
   PubMed Web of Science ®Google Scholar
• Yu J, Huang Y, Song J, et al. Keratoprosthesis sterile vitritis. Ophthalmology 2011;118:221
   PubMed Web of Science ®Google Scholar
• Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea 2005;24:915-19
   PubMed Web of Science ®Google Scholar
• Huang Y, Yu J, Liu L, et al. Moscow eye microsurgery complex in Russia keratoprosthesis in Beijing. Ophthalmology 2011;118:41-6
   PubMedGoogle Scholar
• Banitt M. Evaluation and management of glaucoma after keratoprosthesis. Curr Opin Ophthalmol 2011;22:133-6
   PubMed Web of Science ®Google Scholar
• Talajic JC, Agoumi Y, Gagne S, et al. Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery. Am J Ophthalmol 2012;153:267-74
   PubMed Web of Science ®Google Scholar
• Robert MC, Pomerleau V, Harissi-Dagher M. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices. Br J Ophthalmol 2013;97:573-7
   PubMed Web of Science ®Google Scholar
• Panarelli JF, Ko A, Sidoti PA, et al. Angle closure after Boston keratoprosthesis. J Glaucoma 2013;22:725-9
   PubMed Web of Science ®Google Scholar
• Crnej A, Paschalis EI, Salvador-Culla B, et al. Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis. Cornea 2014;33:349-54
   PubMed Web of Science ®Google Scholar
• Panarelli JF, Banitt MR, Sidoti PA. Scleral fistula closure at the time of glaucoma drainage device tube repositioning: a novel technique. Arch Ophthalmol 2012;130:1447-51
   PubMed Web of Science ®Google Scholar
• Qian CX, Hassanaly S, Harissi-Dagher M. Anterior segment optical coherence tomography in the long-term follow-up and detection of glaucoma in Boston Type I keratoprosthesis. Ophthalmology 2015;122:317-25
   PubMed Web of Science ®Google Scholar
• Kniestedt C, Punjabi O, Lin S, et al. Tonometry through the ages. Surv Ophthalmol 2008;53:568-91
   PubMed Web of Science ®Google Scholar
• Rubinfeld RS, Cohen EJ, Laibson PR, et al. The accuracy of finger tension for estimating intraocular pressure after penetrating keratoplasty. Ophthalmic Surg Lasers 1998;29:213-15
   PubMedGoogle Scholar
• Lin CC, Chen A, Jeng BH, et al. Scleral intraocular pressure measurement in cadaver eyes pre- and postkeratoprosthesis implantation. Invest Ophthalmol Vis Sci 2014;55:2244-50
   PubMedGoogle Scholar
• Todani A, Behlau I, Fava MA, et al. Intraocular pressure measurement by radio wave telemetry. Invest Ophthalmol Vis Sci 2011;52:9573-80
   PubMed Web of Science ®Google Scholar
• Melki S, Todani A, Cherfan G. An implantable intraocular pressure transducer: initial safety outcomes. JAMA Ophthalmol 2014;132:1221-5
   PubMed Web of Science ®Google Scholar
• Li JY, Greiner MA, Brandt JD, et al. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol 2011;152:209-18
   PubMed Web of Science ®Google Scholar
• Patel S, Takusagawa H, Shen L, et al. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol 2012;154:207-8. author reply 8-9
   PubMedGoogle Scholar
• Vajaranant TS, Blair MP, McMahon T, et al. Special considerations for pars plana tube-shunt placement in Boston type 1 keratoprosthesis. Arch Ophthalmol 2010;128:1480-2
   PubMedGoogle Scholar
• Qian CX, Harissi-Dagher M. Delayed suprachoroidal haemorrhage following Boston Keratoprosthesis in two aniridic patients. Br J Ophthalmol 2011;95:436-7
   PubMedGoogle Scholar
• Netland PA, Terada H, Dohlman CH. Glaucoma associated with keratoprosthesis. Ophthalmology 1998;105:751-7
   PubMed Web of Science ®Google Scholar
• Kamyar R, Weizer JS, de Paula FH, et al. Glaucoma associated with Boston type I keratoprosthesis. Cornea 2012;31:134-9
   PubMed Web of Science ®Google Scholar
• Huh ES, Aref AA, Vajaranant TS, et al. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery. J Glaucoma 2014;23:39-44
   PubMed Web of Science ®Google Scholar
• Law SK, Huang JS, Nassiri N, et al. Technique of combined glaucoma tube shunt and keratoprosthesis implantation. J Glaucoma 2014;23:501-7
   PubMed Web of Science ®Google Scholar
• Munoz-Gutierrez G, Alvarez de Toledo J, Barraquer RI, et al. Post-surgical visual outcome and complications in Boston type 1 keratoprosthesis. Arch Soc Esp Oftalmol 2013;88:56-63
   PubMedGoogle Scholar
• Modjtahedi BS, Eliott D. Vitreoretinal complications of the Boston keratoprosthesis. Semin Ophthalmol 2014;29:338-48
   PubMed Web of Science ®Google Scholar
• Dokey A, Ramulu PY, Utine CA, et al. Chronic hypotony associated with the Boston type 1 keratoprosthesis. Am J Ophthalmol 2012;154:266-71
   PubMed Web of Science ®Google Scholar